Central Trust Company’s Axonics, Inc. Common Stock AXNX Stock Holding History

Central Trust Company’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$70	–	1526
2024 Q3	$70	Buy	+1	New	+$69	﹤0.01%	1423

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Central Trust Company's AXNX Position: Q4 2024 in Review

Central Trust Company sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 1 share — an estimated $70 sold.

Central Trust Company first reported a position in AXNX in Q3 2024 and held it in 1 quarter. The position peaked at $70 in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Central Trust Company reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Central Trust Company sold 1 Axonics, Inc. Common Stock share in Q4 2024, an estimated $70.
Central Trust Company first reported a position in Axonics, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Central Trust Company's Axonics, Inc. Common Stock position peaked at $70 in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Central Trust Company's 13F filing for Q4 2024, filed 24 Jan 2025.